一项关于在焦虑门诊患者中联合开具丁螺环酮与组胺H2受体拮抗剂的研究。
A study of buspirone coprescribed with histamine H2-receptor antagonists in anxious outpatients.
作者信息
Levine S, Napoliello M J
机构信息
Oldham & District General Hospital, U.K.
出版信息
Int Clin Psychopharmacol. 1988 Jan;3(1):83-6. doi: 10.1097/00004850-198801000-00007.
Abstract
In a study of a large cohort of patients suffering from anxiety symptoms and treated with the new anxiolytic, buspirone, 0.5% were found to be receiving concomitant histamine H2-receptor antagonist therapy. A study of this subgroup showed that no drug interaction occurred.
摘要
在一项针对大量患有焦虑症状并接受新型抗焦虑药丁螺环酮治疗的患者队列研究中，发现0.5%的患者同时接受组胺H2受体拮抗剂治疗。对该亚组的一项研究表明未发生药物相互作用。
Zotero 插件